Professor | Huilan Liu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Huilan Liu
Contact Information	huilanl@ustc.edu.cn
Language ability	Chinese, English
Province	Anhui

Upload Avatar (500 x 500)

Name

Huilan Liu

Contact Information

huilanl@ustc.edu.cn

Language ability

Chinese, English

Province

Anhui

University/Lab Affiliation and Title	University of Science and Technology of China
Faculty	Mayo Clinic College of Medicine
Academic Background & Achievements	1986/09-1991/07 Bachelor's Degree: Anhui Medical University 2000/09-2003/07 Master's Degree in Biochemistry and Molecular Biology: Anhui Medical University 2009/07-2004/12 Doctorate in Pharmacology: Anhui Medical University Achievement: Completed over 2000 hematopoietic stem cell transplants
Work Experience	1991/07-present - Anhui Provincial Hospital - Department of Internal Medicine/Hematology 1999-present - Focus on hematopoietic stem cell transplantation
Awards	Anhui Science and Technology Progress Award (2014): Second Prize Anhui Science and Technology Progress Award (2011): Second Prize Anhui Science and Technology Progress Award (2000): Second Prize

University/Lab Affiliation and Title

University of Science and Technology of China

Faculty

Mayo Clinic College of Medicine

Academic Background & Achievements

1986/09-1991/07 Bachelor's Degree: Anhui Medical University
2000/09-2003/07 Master's Degree in Biochemistry and Molecular Biology: Anhui Medical University
2009/07-2004/12 Doctorate in Pharmacology: Anhui Medical University
Achievement: Completed over 2000 hematopoietic stem cell transplants

Work Experience

1991/07-present - Anhui Provincial Hospital - Department of Internal Medicine/Hematology
1999-present - Focus on hematopoietic stem cell transplantation

Awards

Anhui Science and Technology Progress Award (2014): Second Prize
Anhui Science and Technology Progress Award (2011): Second Prize
Anhui Science and Technology Progress Award (2000): Second Prize

Areas of Focus	Immune reconstruction after unrelated cord blood transplantation Mechanisms and treatment of post-transplant relapse Improvement of pre-transplant conditioning regimens
Publications	The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases., Cao Y, Gong X, Feng Y, Wang M, Hu Y, Liu H, Liu X, Qi S, Ji Y, Liu F, Zhu H, Guo W, Shen Q, Zhang R, Zhao N, Zhai W, Song X, Chen X, Geng L, Chen X, Zheng X, Ma Q, Tang B, Wei J, Huang Y, Ren Y, Song K, Yang D, Pang A, Yao W, He Y, Shang Y, Wan X, Zhang W, Zhang S, Sun G, Feng S, Zhu X, Han M, Song Z, Guo Y, Sun Z, Jiang E, Chen J., 2023 ABO incompatibility does not affect transfusion requirements or clinical outcomes of unrelated cord blood transplantation after myeloablative conditioning for haematological malignancies., Chen Y, Wan X, Cao Y, Wang H, Han D, Zhang Y, Yao W, Song K, Fan Q, Zhu X, Sun Z, Liu H., 2022 Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine-busulfan-cyclophosphamide-based conditioning., Li G, Sun Z, Geng L, Wan X, Zhu X, Tang B, Tong J, Yao W, Song K, Qiang P, Zhang L, Zhang X, Zhang S, Liu H., 2022 Elevated RAP1A expression correlates with the severity of acute GVHD after umbilical cord blood transplantation., Wang S, Wang D, Chang Y, Geng L, Qiang P, Sun G, Tang B, Zhao X, Zhou Z, Liu H., 2022 Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation., Wang H, Liu H, Zhou L, Wang D, Wang S, Liu Q, Wu Y, Tu M, Sun Z, Zheng X, Fu B, Wang B, Wei H., 2022 Inhibition Effect of Ti3C2Tx MXene on Ice Crystals Combined with Laser-Mediated Heating Facilitates High-Performance Cryopreservation., Cao Y, Chang T, Fang C, Zhang Y, Liu H, Zhao G., 2022 Incidence and risk factors of late-onset hemorrhagic cystitis after single umbilical cord blood transplantation with myeloablative conditioning regimen., Jiang H, Geng L, Wan X, Song K, Tong J, Zhu X, Tang B, Yao W, Zhang X, Sun G, Zhang L, Sun Z, Liu H., 2021 Better outcomes of modified myeloablative conditioning without antithymocyte globulin vs. myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study., Sun Z, Liu H, Luo C, Geng L, Zheng C, Tang B, Zhu X, Tong J, Wang X, Ding K, Wan X, Zhang L, Yao W, Song K, Zhang X, Wu Y, Yang H, Han Y, Liu X, Zhu W, Wu J, Wang Z., 2018

Areas of Focus

Immune reconstruction after unrelated cord blood transplantation
Mechanisms and treatment of post-transplant relapse
Improvement of pre-transplant conditioning regimens

Publications

The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases., Cao Y, Gong X, Feng Y, Wang M, Hu Y, Liu H, Liu X, Qi S, Ji Y, Liu F, Zhu H, Guo W, Shen Q, Zhang R, Zhao N, Zhai W, Song X, Chen X, Geng L, Chen X, Zheng X, Ma Q, Tang B, Wei J, Huang Y, Ren Y, Song K, Yang D, Pang A, Yao W, He Y, Shang Y, Wan X, Zhang W, Zhang S, Sun G, Feng S, Zhu X, Han M, Song Z, Guo Y, Sun Z, Jiang E, Chen J., 2023
ABO incompatibility does not affect transfusion requirements or clinical outcomes of unrelated cord blood transplantation after myeloablative conditioning for haematological malignancies., Chen Y, Wan X, Cao Y, Wang H, Han D, Zhang Y, Yao W, Song K, Fan Q, Zhu X, Sun Z, Liu H., 2022
Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine-busulfan-cyclophosphamide-based conditioning., Li G, Sun Z, Geng L, Wan X, Zhu X, Tang B, Tong J, Yao W, Song K, Qiang P, Zhang L, Zhang X, Zhang S, Liu H., 2022
Elevated RAP1A expression correlates with the severity of acute GVHD after umbilical cord blood transplantation., Wang S, Wang D, Chang Y, Geng L, Qiang P, Sun G, Tang B, Zhao X, Zhou Z, Liu H., 2022
Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation., Wang H, Liu H, Zhou L, Wang D, Wang S, Liu Q, Wu Y, Tu M, Sun Z, Zheng X, Fu B, Wang B, Wei H., 2022
Inhibition Effect of Ti3C2Tx MXene on Ice Crystals Combined with Laser-Mediated Heating Facilitates High-Performance Cryopreservation., Cao Y, Chang T, Fang C, Zhang Y, Liu H, Zhao G., 2022
Incidence and risk factors of late-onset hemorrhagic cystitis after single umbilical cord blood transplantation with myeloablative conditioning regimen., Jiang H, Geng L, Wan X, Song K, Tong J, Zhu X, Tang B, Yao W, Zhang X, Sun G, Zhang L, Sun Z, Liu H., 2021
Better outcomes of modified myeloablative conditioning without antithymocyte globulin vs. myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study., Sun Z, Liu H, Luo C, Geng L, Zheng C, Tang B, Zhu X, Tong J, Wang X, Ding K, Wan X, Zhang L, Yao W, Song K, Zhang X, Wu Y, Yang H, Han Y, Liu X, Zhu W, Wu J, Wang Z., 2018

Immune Reconstruction Cord Blood Transplantation Relapse Treatment Conditioning Regimen Hematopoietic Stem Cell Graft Host Disease

Zhiwei Zhao - University of Science and Technology of China

Changcheng Zheng - University of Science and Technology of China

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us